A study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of AZD5718 after single and multiple ascending dose administration to healthy male subjects

Trial Identifier: D7550C00001
Sponsor: AstraZeneca
NCTID:: NCT02632526
Start Date: February 2016
Primary Completion Date: August 2016
Study Completion Date: August 2016
Condition: Heart, Blood & Circulatory - Other; Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Translation
English Translation

Trial Locations

Country Location
United Kingdom Harrow, United Kingdom, HA1 3UJ